Dowling & Yahnke’s Avidity Biosciences RNA Stock Holding History

Dowling & Yahnke’s Portfolio RNA Stock Details RNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$175K	Sell
2022 Q2	$164K	Hold
2022 Q1	$208K	Hold
2021 Q4	$268K	Hold
2021 Q3	$278K	Sell
2021 Q2	$340K	Hold
2021 Q1	$300K	Buy